Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |